AGP Picks
View all

STEM News Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM News Today.

Press releases published on November 18, 2026

Robotimize Bridges Medical Design and Rehabilitation Technology at Conference Innovation Visits
Five Reputable Research Program Providers for High School Students in China 2026: Advancing Academic Excellence
Urological Endoscopy Consumables: How ZRHmed Delivers High-Performance Ureteral Access Sheaths
Visit ZRHmed at MEDICA to Discover Next-Gen Single-Use Endoscopic Consumables
Top 5 Reasons Endoscopy Centers Partner with ZRHmed for Single-Use GI Consumables
Preventing Iatrogenic Complications in ESD and EMR Procedures: Best Practices for Device Selection
Hydrophilic Guide Wires for Endoscopy: ZRHmed Smooth Crossability in Tortuous Ducts
Disposable Biopsy Forceps and Cytology Brushes: The ZRHmed Standard for Diagnostic Yield
Disposable Polypectomy Snares: Why Gastroenterologists Choose ZRHmed for Precision Resection
Disposable Endoscopic Hemoclips: How ZRHmed Ensures Reliable Hemostasis in GI Bleeding
ZRHmed at Arab Health: Showcasing Advanced Endoscopic and Urological Devices to Middle East Clinics
Cold Snare vs Hot Snare Polypectomy: Clinical Guidelines for Colorectal Polyps under 10mm
SciSure Appoints Former HCA Healthcare CIO Marty Paslick to Board of Directors
CellNet™ PR: World’s First & Only Commercial Whole Blood Inline Leukoreduction Filter, No Solvents,No Process Wastewater
CMS Finalizes Reassignment of Gastric Alimetry® Test to Higher Payment Level, Increasing Medicare Hospital Outpatient Payment by Approximately 144%
KBR Announces Launch of Trinzic’s Senior Notes Offering
TTEC Identifies Six CX Trends Businesses Must Prepare for in 2027
Immuneering Presents Additional Data Demonstrating Atebimetinib’s Broad Potential as a Backbone for Combination Therapy in Pancreatic Cancer
Immuneering Presents Data That Supports Expanding the Clinical Evaluation of Atebimetinib to Anaplastic Thyroid Cancer
SELLAS Life Sciences meldet positive Ergebnisse der zulassungsrelevanten Phase III-Studie REGAL zu immuntherapeutischem Krebsimpfstoff Galinpepimut-S (GPS), die eine statistisch signifikante und klinisch bedeutsame Verbesserung in Bezug auf…

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

STEM News Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.